The hypothesis that the functionally active anti-AT1R-antibodies may belong to the pool of naturally occurring antibodies is underlined by our observation that they have been been detected in a rather high prevalence of 70% in patients with viral and toxic liver diseases. This evidence concerns the gene AGTR1 and drug-induced liver injury.